← Shenyang Cuihua Gold and Silver Jewelry overview

Shenyang Cuihua Gold and Silver Jewelry vs Hermes International SCA: why the prices moved differently

Weekly · monthly · quarterly news summaries, side by side in time

Shenyang Cuihua Gold and Silver Jewelry Co Ltd (002731.CS)

Q3 202615 Jul – 1 Sep 2026

▼4

Cuihua's Delisting Locked In as Reports Miss Deadlines

Actual controller under CSRC investigation On August 4, Cuihua's controlling shareholder Chen Siwei and a major shareholder were placed under CSRC investigation for suspected illegal information disclosure. This is the third probe this year, deepening regulatory risk and making a major-violation delisting more likely, which pressures the stock.
This is a new regulatory escalation that directly raises the risk of forced delisting.
Suspected false financial records found On August 6, regulators said a preliminary probe found suspected false records in Cuihua's annual financial information. This could trigger mandatory delisting for major violations, adding another path to removal from the exchange and weighing heavily on the shares.
It reveals a new fraud allegation that independently threatens delisting.
Market value and price fall below delisting thresholds By late August, Cuihua's market value stayed under 500 million yuan for 16 straight days and its share price fell below 1 yuan. Both are automatic delisting triggers if they persist, so the stock is now locked into delisting, crushing any recovery hope.
It shows the stock has hit hard delisting thresholds, making removal nearly certain.
Annual report still missing; trading suspended and delisting set Cuihua failed to release its 2025 annual report and 2026 semi-annual report by the deadlines, so trading was suspended from September 1. The exchange now intends to terminate its listing, meaning shareholders face a likely total loss with no easy exit.
It confirms the final regulatory step—delisting—and the loss of trading liquidity.

August 202615 Jul – 1 Sep 2026

▼4

Cuihua's Delisting Locked In as Reports Miss Deadlines

Actual controller under CSRC investigation On August 4, Cuihua's controlling shareholder Chen Siwei and a major shareholder were placed under CSRC investigation for suspected illegal information disclosure. This is the third probe this year, deepening regulatory risk and making a major-violation delisting more likely, which pressures the stock.
This is a new regulatory escalation that directly raises the risk of forced delisting.
Suspected false financial records found On August 6, regulators said a preliminary probe found suspected false records in Cuihua's annual financial information. This could trigger mandatory delisting for major violations, adding another path to removal from the exchange and weighing heavily on the shares.
It reveals a new fraud allegation that independently threatens delisting.
Market value and price fall below delisting thresholds By late August, Cuihua's market value stayed under 500 million yuan for 16 straight days and its share price fell below 1 yuan. Both are automatic delisting triggers if they persist, so the stock is now locked into delisting, crushing any recovery hope.
It shows the stock has hit hard delisting thresholds, making removal nearly certain.
Annual report still missing; trading suspended and delisting set Cuihua failed to release its 2025 annual report and 2026 semi-annual report by the deadlines, so trading was suspended from September 1. The exchange now intends to terminate its listing, meaning shareholders face a likely total loss with no easy exit.
It confirms the final regulatory step—delisting—and the loss of trading liquidity.

Latest15 Jul – 1 Sep 2026

▼4

Cuihua's Delisting Locked In as Reports Miss Deadlines

Actual controller under CSRC investigation On August 4, Cuihua's controlling shareholder Chen Siwei and a major shareholder were placed under CSRC investigation for suspected illegal information disclosure. This is the third probe this year, deepening regulatory risk and making a major-violation delisting more likely, which pressures the stock.
This is a new regulatory escalation that directly raises the risk of forced delisting.
Suspected false financial records found On August 6, regulators said a preliminary probe found suspected false records in Cuihua's annual financial information. This could trigger mandatory delisting for major violations, adding another path to removal from the exchange and weighing heavily on the shares.
It reveals a new fraud allegation that independently threatens delisting.
Market value and price fall below delisting thresholds By late August, Cuihua's market value stayed under 500 million yuan for 16 straight days and its share price fell below 1 yuan. Both are automatic delisting triggers if they persist, so the stock is now locked into delisting, crushing any recovery hope.
It shows the stock has hit hard delisting thresholds, making removal nearly certain.
Annual report still missing; trading suspended and delisting set Cuihua failed to release its 2025 annual report and 2026 semi-annual report by the deadlines, so trading was suspended from September 1. The exchange now intends to terminate its listing, meaning shareholders face a likely total loss with no easy exit.
It confirms the final regulatory step—delisting—and the loss of trading liquidity.

Hermes International SCA (RMS.PA)

Q3 202629 Jul – 30 Jul 2026

▼3▲1

Hermès beats on earnings but China worries and Kering's rebound drag shares

Strong first-half results Hermès reported first-half revenue of €8.2 billion, up 6% at constant currencies, with a 41% operating margin and €2.2 billion free cash flow. All regions grew except the Middle East, and the company confirmed its medium-term growth goal. This solid performance supports the stock's value.
This is the core fundamental news that reassures investors about Hermès' financial health.
Kering's Gucci turnaround pressures luxury peers Kering shares jumped 15% as Gucci's sales decline was less severe than feared, prompting analyst upgrades. This shift in market sentiment led to a rotation out of Hermès, which fell over 12% as investors anticipated a normalization of its growth rates. Competition is intensifying.
It explains a key reason for Hermès' sharp share price drop despite good earnings.
China recovery remains elusive Hermès shares slumped 11% amid no signs of recovery in the Chinese market, a crucial region for luxury goods. This persistent weakness raises concerns about future demand and growth prospects, overshadowing the company's otherwise strong first-half performance.
It highlights a major geographic risk that is currently weighing on the stock.
Valuation concerns after earnings Following the earnings report, Hermès stock closed at €1,550.50, about 3% above a narrative fair value of €1,505. With shares down 26% year-to-date, the valuation remains in focus, and unresolved issues like the missing €14 billion share saga add uncertainty.
It shows that even with strong results, the stock may be overvalued, limiting upside.

July 202629 Jul – 30 Jul 2026

▼3▲1

Hermès beats on earnings but China worries and Kering's rebound drag shares

Strong first-half results Hermès reported first-half revenue of €8.2 billion, up 6% at constant currencies, with a 41% operating margin and €2.2 billion free cash flow. All regions grew except the Middle East, and the company confirmed its medium-term growth goal. This solid performance supports the stock's value.
This is the core fundamental news that reassures investors about Hermès' financial health.
Kering's Gucci turnaround pressures luxury peers Kering shares jumped 15% as Gucci's sales decline was less severe than feared, prompting analyst upgrades. This shift in market sentiment led to a rotation out of Hermès, which fell over 12% as investors anticipated a normalization of its growth rates. Competition is intensifying.
It explains a key reason for Hermès' sharp share price drop despite good earnings.
China recovery remains elusive Hermès shares slumped 11% amid no signs of recovery in the Chinese market, a crucial region for luxury goods. This persistent weakness raises concerns about future demand and growth prospects, overshadowing the company's otherwise strong first-half performance.
It highlights a major geographic risk that is currently weighing on the stock.
Valuation concerns after earnings Following the earnings report, Hermès stock closed at €1,550.50, about 3% above a narrative fair value of €1,505. With shares down 26% year-to-date, the valuation remains in focus, and unresolved issues like the missing €14 billion share saga add uncertainty.
It shows that even with strong results, the stock may be overvalued, limiting upside.

Latest29 Jul – 30 Jul 2026

▼3▲1

Hermès beats on earnings but China worries and Kering's rebound drag shares

Strong first-half results Hermès reported first-half revenue of €8.2 billion, up 6% at constant currencies, with a 41% operating margin and €2.2 billion free cash flow. All regions grew except the Middle East, and the company confirmed its medium-term growth goal. This solid performance supports the stock's value.
This is the core fundamental news that reassures investors about Hermès' financial health.
Kering's Gucci turnaround pressures luxury peers Kering shares jumped 15% as Gucci's sales decline was less severe than feared, prompting analyst upgrades. This shift in market sentiment led to a rotation out of Hermès, which fell over 12% as investors anticipated a normalization of its growth rates. Competition is intensifying.
It explains a key reason for Hermès' sharp share price drop despite good earnings.
China recovery remains elusive Hermès shares slumped 11% amid no signs of recovery in the Chinese market, a crucial region for luxury goods. This persistent weakness raises concerns about future demand and growth prospects, overshadowing the company's otherwise strong first-half performance.
It highlights a major geographic risk that is currently weighing on the stock.
Valuation concerns after earnings Following the earnings report, Hermès stock closed at €1,550.50, about 3% above a narrative fair value of €1,505. With shares down 26% year-to-date, the valuation remains in focus, and unresolved issues like the missing €14 billion share saga add uncertainty.
It shows that even with strong results, the stock may be overvalued, limiting upside.